Financials
Financial year 2022
Worth noting
- More debts than assets in the latest financial year.
- A loss two years in a row.
- Little cash and receivables against the short-term debts.
Gross margin
€ 217,567
▲ 228% vs 2021
Profit
Caution€ -825,129
▲ 27% vs 2021
Debts
High€ 6.9 million
▲ 52% vs 2021
Texere Biotech from Les Bons Villers, company number BE0666661105, closed financial year 2022 with a result of € -825,129 after tax. For that financial year Texere Biotech recorded a gross margin of € 217,567 and equity of € -710,144. Compared with financial year 2021, the result moved from € -1.1 million to € -825,129. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 1, 2023.
What happened at Texere Biotech?
What happened at Texere Biotech in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2022: loss of € 825,129. Source: NBB ↗
- François Fontaine became a director. NBB
- Luc Bülhmann became a director. NBB
- New establishment in Les Bons Villers. KBO
- PROGERA SRL became a director. NBB
- THERACELL CONSULTING became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 1.1 million loss in 2021 to € 825,129 loss in 2022.
Paid € 1,584 in corporate taxes since 2021.
On average € 27,500 of value added per employee in 2022.
A new publication or filing at Texere Biotech? We notify you, reason included.
Follow Texere BiotechNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind Texere Biotech are PROGERA SRL, François Fontaine, THERACELL CONSULTING and Luc Bülhmann. The same people are also behind COMETSAMBRE, COMET TRAITEMENTS, OncoDNA, EPIMEDE and PDC line Pharma.
Directors
According to the 2022 annual accounts
Director · represented by Jean-Jacques Dufrane
since 2016
since 2020
since 2016
Luc Bülhmann
Director
since 2020
Establishments
Establishment units
Physical locations of this company
Rue des Artisans(FLG) 4 box a
6210 Les Bons Villers
Rue des Artisans(FLG) 4 box A
6210 Les Bons Villers
Active since 2 December 2016
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
Details
- Company number
- 0666.661.105
- VAT number
- BE 0666.661.105
- Registered office
- Rue des Artisans(FLG) 4 bus a, 6210 Les Bons Villers
- Names & denominations
- Texere Biotech
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Opening faillissement
- Start date
- 24 November 2016
- Peppol
- Not registered
- Activities · NACE
Groothandel in andere intermediaire producten, neg
Groothandel in andere intermediaire producten, n.e.g.
Speur- en ontwikkelingswerk op biotechnologisch gebied
Overige zakelijke dienstverlening, neg